| 冯虹,钱建军,董莹盈,马灵亚,吴桂红,沈藕英.认识领悟疗法对持续性躯体形式疼痛障碍患者述情障碍的疗效观察[J].中国康复,2014,29(1):35-37 |
| 认识领悟疗法对持续性躯体形式疼痛障碍患者述情障碍的疗效观察 |
| Cognitive insight therapy for alexithymia in patients with persistent somatoform pain disorder |
| |
| DOI： |
| 中文关键词: 认识领悟疗法 持续性躯体形式疼痛障碍 述情障碍 临床疗效 |
| 英文关键词: cognitive insight therapy persistent somatoform pain disorder alexithymia clinical treatment |
| 基金项目: |
|
| 摘要点击次数: 8571 |
| 全文下载次数: 6869 |
| 中文摘要: |
| 目的：探讨认知领悟疗法治疗持续性躯体形式疼痛障碍患者述情障碍的临床疗效。方法：将60例持续性躯体形式疼痛障碍患者分为观察组和对照组各30例，2组均口服抗抑郁药度罗西汀治疗。观察组同时进行认识领悟治疗。治疗前后应用多伦多述情障碍量表（TAS）评定疗效。结果：治疗8周后，观察组TAS总分和因子1、2、4得分均较治疗前及对照组明显降低（P<0.01,0.05），观察组因子3、对照组TAS总分及各因子治疗前后比较差异均无统计学意义。结论:认知领悟疗法能有效治疗持续性躯体形式疼痛障碍患者的述情障碍，值得临床借鉴。 |
| 英文摘要: |
| Objective:To explore the clinical efficacy of cognitive insight therapy for alexithymia in patients with persistent somatoform pain disorder.Methods:Totally 60 patients with persistent somatoform pain disorder were divided into observation group (n=30) and control group (n=30).All the patients were treated with antidepressants (Duloxetine),and those in the observation group received cognitive insight therapy additionally.The efficacy was evaluated with the Toronto alexithymia scale (TAS) before and after treatment.Results:After treatment for 8 weeks,the total score of TAS,scores of factor Ⅰ,factor Ⅱ and factor Ⅳ in observation group were significantly lower than those before treatment and control group(P<0.05),and there was no significant difference in the score of factor Ⅲ in observation group and all scores in control group.Conclusion:Cognitive insight therapy can effectively treat alexithymia in patients with persistent somatoform pain disorder. |
|
查看全文
下载PDF阅读器 HTML全文 |
| 关闭 |
